CompaniesNascent Biologics

Nascent Biologics

defunct

About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

565

By Phase

PHASE3: 1

By Status

COMPLETED: 2

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

Today

Hover over trial bars to see details

Recent Trials

NCT01426815Collaborator

Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria

PHASE3Completed

60 participants

Started: Mar 13, 2012 · Completed: Mar 18, 2019

NCT00207688Collaborator

A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

505 participants

Started: Aug 31, 2004 · Completed: Sep 9, 2015

Funding History (1)

D

Jun 28, 2011